Characteristics, clinical outcomes and patient-reported outcomes of patients with ulcerative colitis receiving tofacitinib: a real-world survey in the United States and five European countries

BACKGROUND: To describe variations in treatment patterns, clinical outcomes, patient-reported outcomes (PRO), and physician and patient satisfaction in patients with moderate-to-severe ulcerative colitis (UC) treated with tofacitinib in a real-world setting. METHODS: Data were drawn from the Adelphi...

Descripción completa

Detalles Bibliográficos
Autores principales: Armuzzi, Alessandro, Hart, Ailsa, Cappelleri, Joseph C., Mammar, Nadir, Hur, Peter, Hoskin, Benjamin, Hennessy, Fritha, Milligan, Gary, Dignass, Axel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849840/
https://www.ncbi.nlm.nih.gov/pubmed/36658481
http://dx.doi.org/10.1186/s12876-023-02640-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849840/
https://www.ncbi.nlm.nih.gov/pubmed/36658481
http://dx.doi.org/10.1186/s12876-023-02640-7

Ejemplares similares